Regulatory Strategies

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA’s generative AI discussion paper points to competency-style evaluation and heavier postmarket monitoring, pushing vendors and hospital buyers to demand

Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

Data-driven insights reveal hidden inefficiencies in promotional material review workflows, transforming compliance processes into competitive advantages

From Content Scramble to Streamlined Success: Demystifying Modular Content in Life Sciences

Life sciences teams are discovering that breaking content into reusable pieces can dramatically cut production time while improving compliance and personalizati

Aligning, Appraising, and Simplifying Scientific Data Strengthens Promotional Claims

Pharmaceutical marketers must translate dense scientific evidence into compliant promotional messaging without losing accuracy or impact

Strategic Engagement and Clear Communication Optimize Agency Input for Material Review Process Success

Organizations unlock better outcomes by establishing transparent workflows and intentional touchpoints with their agency partners throughout material reviews

The Missing Piece for MLR Team’s Success is Defining Clear Roles in the Promotional Material Review Process

Ambiguous responsibilities in promotional review workflows create bottlenecks that slow market launches and increase compliance risk

Collecting Healthcare Debt in Highly Regulated Conditions

Healthcare providers must navigate a complex web of regulatory changes while pursuing outstanding patient balances

Exploring the Fundamentals of Validation in Life Science Manufacturing

Regulatory pressures are forcing life science manufacturers to rethink how they prove product quality and safety at every stage